Ledermycin

Demeclocycline Hydrochloride, the active ingredient in Ledermycin, is a tetracycline antibiotic presented as an oral formulation for systemic use. It is employed to treat acne vulgaris and to manage the syndrome of inappropriate antidiuretic hormone secretion (SIADH) in adult patients. It is indicated for adult patients who require long‑term therapy and is available under prescription only.

GNH USA supplies Ledermycin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch.

Demeclocycline Hydrochloride is used in conditions where bacterial protein synthesis inhibition or antidiuretic hormone modulation is required. - Acne vulgaris: reduces inflammatory lesions and bacterial colonization on the skin. - Syndrome of inappropriate antidiuretic hormone secretion (SIADH): helps correct hyponatremia by inducing nephrogenic diabetes insipidus.

Demeclocycline Hydrochloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Photosensitivity - Taste disturbance

Serious or Rare Side Effects: - Hepatic toxicity - Stevens‑Johnson syndrome - Anaphylactic reaction

Before prescribing Demeclocycline, clinicians should consider several precautionary measures. - Assess renal function: adjust use in patients with impaired clearance. - Monitor liver enzymes: discontinue if significant hepatic injury occurs. - Avoid in children under 8 years: risk of permanent tooth discoloration. - Contraindicated in pregnancy: potential teratogenic effects; use only if benefits outweigh risks. - Caution in patients on lithium: may increase lithium levels. - Store at ambient temperature: keep in the original pack, protect from moisture.

Demeclocycline can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Concurrent tetracyclines: additive toxicity. - Antacids or supplements containing aluminum, magnesium, calcium, or iron: reduce absorption. - Warfarin: may enhance anticoagulant effect and increase INR. - Isotretinoin: heightened risk of intracranial hypertension.

Moderate Interactions (Monitor Closely): - Oral contraceptives: reduced hormonal efficacy, consider backup method. - Macrolide antibiotics: increased gastrointestinal adverse effects. - Lithium: possible elevation of serum lithium concentrations.